GL vs IMNM · P/E 10, rev $3.16B vs $2.47B cap
Globe Life Inc (GL) versus Immunome Inc (IMNM) — a side-by-side from cached financials, not a winner call.
Globe Life Inc (GL) is a insurance - life company listed on US.
Immunome Inc (IMNM) is a biotechnology company listed on US.
Latest reported GL revenue for 2026-06-30 was $3.16B. Net income was $558.3M. GL currently screens at market cap $10.26B and trailing P/E 10.1.
Latest reported IMNM revenue for 2026-06-30 was $0. Net income was -$127.0M. IMNM currently screens at market cap $2.47B.
GL currently screens at market cap $10.26B and trailing P/E 10.1. IMNM currently screens at market cap $2.47B.
Not investment advice. Open the GL and IMNM stock pages for the full models.
Not investment advice.